Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Hundreds of kilos of protected plant seized by Israel Nature and Parks Authority in Golan - 2January full moon wows skywatchers with a striking 'Wolf Supermoon' (photos)
- 3Electric discovery on Mars! Scientists find tiny lightning bolts coming from Red Planet dust clouds
- 4Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- 5New York to require social media platforms to display mental health warnings
- 'The best gift ever': Baby is born after the rarest of pregnancies, defying all odds
- Do you lean your seat back on the plane? These travel pros — and real-life couple — won't do it.
- New method spots signs of Earth's primordial life in ancient rocks
- Israel’s mixed messaging on Christmas draws controversy
- U.S. overhauls childhood vaccine schedule, recommends fewer shots
- Mexican Woman Accused of Assaulting Partner With Belt After He Refused Sex, Police Say
- IDF says up to 90% of Iran’s weapons industry could be hit within days
- Picking the Right Home Machines: A Commonsense Aide
- FDA updates risk classification for voluntary shredded cheese recall
